GENERALIZED MYASTHENIA GRAVIS (GMG)
Clinical trials for GENERALIZED MYASTHENIA GRAVIS (GMG) explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS (GMG) trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS (GMG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost muscle disease treatment
Disease control Recruiting nowThis study is testing whether adding a new drug called empasiprubart to an existing treatment (efgartigimod) can better control symptoms of myasthenia gravis. It will involve about 70 adults with a specific type of this muscle-weakening disease who have had only a partial improve…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Muscle-Weakening disease: multiple drug trials launch
Disease control Recruiting nowThis study aims to test the safety and effectiveness of several different drug combinations for people with myasthenia gravis, a condition that causes muscle weakness. It will enroll about 70 adults who have been diagnosed with the disease and are on stable treatment. The goal is…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First-of-its-Kind cell therapy tested for debilitating muscle disease
Disease control Recruiting nowThis is a very early study testing a new type of treatment called GC012F, a CAR-T cell therapy, for people with severe myasthenia gravis that hasn't responded to standard treatments. The main goals are to check if the treatment is safe and to look for early signs that it might he…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New shot tested to halt dangerous Muscle-Weakening crises
Disease control Recruiting nowThis study is testing whether daily injections of the drug zilucoplan can quickly relieve the most severe symptoms of a myasthenia gravis flare-up, such as breathing or swallowing problems, in people who need to be hospitalized. The goal is to see if this treatment works faster a…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Phase: PHASE3 • Sponsor: Miriam Freimer • Aim: Disease control
Last updated Mar 02, 2026 15:34 UTC
-
Doctors track 450 patients to map Real-World MG care
Knowledge-focused Recruiting nowThis study aims to understand how doctors in Russia currently treat adults with a specific form of myasthenia gravis (gMG) in everyday practice. It will observe 450 patients over three years, collecting information from their medical records about the treatments they receive and …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Tracking baby health: study follows pregnant women on rare disease drug
Knowledge-focused Recruiting nowThis study aims to gather information on the safety of the drug Ultomiris (ravulizumab) during pregnancy and breastfeeding. It will follow about 75 women who have rare conditions like PNH or aHUS and who took Ultomiris while pregnant. Researchers will track the health of both the…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Feb 23, 2026 14:57 UTC